Skip to main content

Advertisement

SpringerLink
Log in

Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction/objectives

Rheumatoid arthritis (RA) is known to be associated with an increased risk of comorbidities, premature mortality, and disability. We investigated the prevalence of comorbidities in RA compared with non-RA controls and the effect of comorbidities on health-related quality of life (HRQoL) and total healthcare expenditures.

Methods

Adult RA patients and age-, sex-matched individuals without RA (non-RA controls) were identified from the Medical Expenditure Panel Survey 2010–2015 data. Twenty comorbidities were investigated including cardiovascular, psychological, respiratory, and musculoskeletal conditions. The Short Form-12 physical and mental component summary scores for HRQoL and total healthcare expenditures (2015 US dollars) were summarized based on the number of comorbidities as well as the type of comorbidities. Outcomes were further investigated using multivariable regression analyses.

Results

A total of 2925 patients with RA and 14,625 non-RA controls were included. Approximately 60.4% of RA and 37.2% of non-RA controls had ≥ 3 comorbidities, and 23.5% of RA and 12.0% of non-RA controls had ≥ 5 comorbidities. The prevalence of comorbidities in RA was higher across different types of comorbidities compared with non-RA controls. The most prevalent comorbidities in RA were cardiovascular diseases (79.0%) followed by respiratory conditions (34.4%). Having ≥ 5 comorbidities in RA was significantly associated with lower SF-12 physical and mental scores and increase in healthcare expenditures compared with RA without any comorbidity ($23,214 ($19,941–$26,119) for ≥ 5 comorbidities vs. $11,137 ($7610–$14,396) for no comorbidity).

Conclusion

A substantial number of patients with RA had multiple comorbidities. The comorbidities in RA were associated with poor HRQoL and higher healthcare expenditures.

Key Points

• The prevalence of comorbidities was significantly higher in RA compared to age- and sex-matched non-RA controls.

• RA itself was associated with lower mental and physical health-related quality of life and increase in healthcare expenditures.

• A higher number of comorbidities in RA were associated with poorer mental and physical health-related quality of life and increase in healthcare expenditures.

• Specific comorbidities such as respiratory conditions and psychological disorders were associated with both health-related quality of life and economic burden in RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet. 388(10055):2023–2038

    Article  CAS  Google Scholar 

  2. Myasoedova E, Crowson CS, Kremers HM, Therneau TM (2010) Gabriel SE. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955–2007. Arthritis Rheum 62(6):1576–1582

    Article  Google Scholar 

  3. GBD 2015 Neurological Disorders Collaborator Group (2017 Nov) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol 16(11):877–897

    Article  Google Scholar 

  4. Gibofsky A (2014) Current therapeutic agents and treatment paradigms for the management of rheumatoid arthritis. Am J Manag Care 20(7 Suppl):S136–S144

    PubMed  Google Scholar 

  5. Cutolo M, Kitas GD, van Riel PL (2014 Feb) Burden of disease in treated rheumatoid arthritis patients: going beyond the joint. Semin Arthritis Rheum 43(4):479–488

    Article  Google Scholar 

  6. Westlake SL, Colebatch AN, Baird J, Kiely P, Quinn M, Choy E, Ostor AJK, Edwards CJ (2010) The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) 49(2):295–307

    Article  CAS  Google Scholar 

  7. Ungprasert P, Wijarnpreecha K, Thongprayoon C (2016) Rheumatoid arthritis and the risk of dementia: a systematic review and meta-analysis. Neurol India 64:56–61

    Article  Google Scholar 

  8. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta analysis of observational studies. Ann Rheum Dis 71:1524–1529

    Article  Google Scholar 

  9. Ungprasert P, Srivali N, Cheungpasitporn W, Davis Iii JM (2016) Risk of incident chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a systematic review and meta-analysis. Joint Bone Spine 83(3):290–294

    Article  Google Scholar 

  10. Drosselmeyer J, Jacob L, Rathmann W, Rapp M, Kostev K (2017) Depression risk in patients with late-onset rheumatoid arthritis in Germany. Qual Life Res 26(2):437–443

    Article  Google Scholar 

  11. Dagan A, Segal G, Tiosano S, Watad A, Neumann SG, Comaneshter D, Cohen AD, Amital H (2017) Coexistent malignant conditions in rheumatoid arthritis—a population-based cross-sectional study. Int J Clin Pract 71(3–4)

    Article  Google Scholar 

  12. Gabriel SE, Crowson CS, O Fallon WM (1999) Comorbidity in arthritis. J Rheumatology 26:2475–2479

    CAS  Google Scholar 

  13. Mikuls TR, Saag KG (2001) Comorbidity in rheumatoid arthritis. Rheum Dis Clin N Am 27(2):283–303

    Article  CAS  Google Scholar 

  14. Radber H (2016) Multimorbidity in rheumatic conditions. Wien Klin Wochenschr 128(21–22):786–790

    Google Scholar 

  15. Van den Hoek J, Boshuizen HC, Roorda LD, Tijhuis GJ, Nurmohamed MT, van den Bos GA et al (2017) Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study. Rheumatol Int 37(4):487–493

    Article  Google Scholar 

  16. Innala L, Sjöberg C, Möller B, Ljung L, Smedby T, Södergren A, Magnusson S, Rantapää-Dahlqvist S, Wållberg-Jonsson S (2016) Co-morbidity in patients with early rheumatoid arthritis—inflammation matters. Arthritis Research & Therapy 18:33. https://doi.org/10.1186/s13075-016-0928-y

    Article  CAS  Google Scholar 

  17. Geryk LL, Carpenter DM, Blalock SJ, DeVellis RF, Jordan JM (2015) The impact of co-morbidity on health-related quality of life in rheumatoid arthritis and osteoarthritis patients. Clin Exp Rheumatol 33(3):366–374

    PubMed  Google Scholar 

  18. Gong G, Mao J (2016 Jan-Feb) Health-related quality of life among Chinese patients with rheumatoid arthritis: the predictive roles of fatigue, functional disability, self-efficacy, and social support. Nurs Res 65(1):55–67

    Article  Google Scholar 

  19. Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, Scott DL, Steer S (2014) The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum 44(2):123–130

    Article  Google Scholar 

  20. Kawatkar AA, Jacobsen SJ, Levy GD, Medhekar SS, Venkatasubramaniam KV, Herrinton LJ (2012) Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey. Arthritis Care Res (Hoboken) 64(11):1649–1656

    Article  Google Scholar 

  21. Birnbaum H, Pike C, Kaufman R, Marynchenko M, Kidolezi Y, Cifaldi M (2010) Societal cost of rheumatoid arthritis patients in the US. Curr Med Res Opin 26(1):77–90

    Article  Google Scholar 

  22. Han GM, Han XF (2016) Comorbid conditions are associated with healthcare utilization, medical charges and mortality of patients with rheumatoid arthritis. Clin Rheumatol 35(6):1483–1492

    Article  Google Scholar 

  23. Agency for Healthcare and Research Quality. MEPS HC-120: 2011–2013 medical conditions. http://www.meps.ahrq. Accessed February 4, 2016

  24. Kim SY, Servi A, Polinski JM, Mogun H, Weinblatt ME, Katz JN, Solomon DH (2011) Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther 13(1):R32

    Article  Google Scholar 

  25. Goodman RA, Posner SF, Huang ES, Parekh AK, Koh HK (2013) Defining and measuring chronic conditions: imperatives for research, policy, program, and practice. Prev Chronic Dis 10:E66

    PubMed  PubMed Central  Google Scholar 

  26. Brazier JE, Roberts J (2004) The estimation of a preference-based index from the SF-12. Med Care 42:851–859

    Article  Google Scholar 

  27. Consumer Price Index, Bureau of Labor Statistics. United States Department of Labor. https://www.bls.gov/cpi/. Accessed February 4, 2016

  28. Hitchon C, Boire G, Haraoui G, Keystone E, Pope J, Jamal S et al (2016) Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian early arthritis cohort. Rheumatology (Oxford) 55(10):1751–1762

    Article  Google Scholar 

  29. Jeong H, Baek SY, Kim SW, Eun YH, Kim IY, Kim H, Lee J, Koh EM, Cha HS (2017) Comorbidities of rheumatoid arthritis: results from the Korean National Health and Nutrition Examination Survey. PLoS One 12(4):e0176260

    Article  Google Scholar 

  30. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 43:522–530

    Article  CAS  Google Scholar 

  31. Pereira IA, Mota L, Cruz BA, Brenol CV, Fronza LS, Bertolo MB et al (2012) 2012 Brazilian Society of Rheumatology Consensus on the management of comorbidities in patients with rheumatoid arthritis. Rev Bras Reumatol 52(4):474–495

    PubMed  Google Scholar 

  32. Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76(1):17–28

    Article  CAS  Google Scholar 

  33. Westlake SL, Colebatch AN, Baird J, Curzen N, Kiely P, Quinn M, Choy E, Ostor AJK, Edwards CJ (2011) Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) 50(3):518–531

    Article  CAS  Google Scholar 

  34. Mourgues C, Blanquet M, Gerbaud L, Soubrier M, Dougados M (2017) Economic analysis of a nurse-led programme for comorbidities management of rheumatoid arthritis patients. Joint Bone Spine

  35. Marion CE, Balfe LM (2011) Potential advantages of interprofessional care in rheumatoid arthritis. J Manag Care Pharm 17(9 Suppl B):S25–S29

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S Los Robles, 2nd Floor, Pasadena, CA, 91101, USA

    JaeJin An

  2. Department of Pharmacy Practice & Administration, Western University of Health Sciences, Pomona, CA, USA

    JaeJin An, Eric Nyarko & Mohammad Adam Hamad

Authors
  1. JaeJin An
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric Nyarko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Adam Hamad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to JaeJin An.

Ethics declarations

The manuscript does not contain clinical studies or patient data. This study analyzed the publicly available data sets, and the data available to the public are not individually identifiable.

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

An, J., Nyarko, E. & Hamad, M.A. Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis. Clin Rheumatol 38, 2717–2726 (2019). https://doi.org/10.1007/s10067-019-04613-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04613-2

Keywords

Search

Navigation